NCT03391609 is a Phase 2, PHASE3 clinical trial of Dexmedetomidine infusion in Pre-Eclampsia, sponsored by Assiut University.

Who is sponsoring NCT03391609?

NCT03391609 is sponsored by Assiut University.

What drugs are being tested in NCT03391609?

Interventions in NCT03391609: placebo infusion, Dexmedetomidine infusion.

What condition does NCT03391609 study?

NCT03391609 studies Pre-Eclampsia.

Is NCT03391609 still recruiting?

NCT03391609 is currently completed. Last updated 26 February 2019.

Last reviewed 2019-02-26 · How we verify

NCT03391609

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients

Completed Phase 2, PHASE3 Last updated 26 February 2019

What this trial tests

Phase 2, PHASE3 trial testing placebo infusion in Pre-Eclampsia in 30 participants. Completed in 1 January 2019.

Timeline

18 June 2017

Primary endpoint
1 November 2018

1 January 2019

Quick facts

Lead sponsor	Assiut University
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	30
Start date	18 June 2017
Primary completion	1 November 2018
Estimated completion	1 January 2019
Sites	1 location across Egypt

Drugs / interventions tested

placebo infusion — full drug profile →
Dexmedetomidine infusion

Conditions studied

Pre-Eclampsia — all drugs for Pre-Eclampsia →

Sponsor

Assiut University

Who can join

Adults 19 to 40, female only, with Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effects of dexmedetomidine infusion on the stress response to intubation, postoperative analgesia, and renal functions (urinary output \[UOP\], creatinine and glomerular filtration rate \[GFR\]) in preeclamptic patient.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine infusion

Trials testing the same drug.

NCT07434310 — Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults · Phase 3 · not yet recruiting
NCT06738043 — Dexmedetomidine Versus Ketamine as Adjuvants in Bariatric Surgery · NA · not yet recruiting
NCT06970678 — Combining Dexmedetomidine Infusion and Paragastric Autonomic Neural Block to Enhance Postoperative Recovery in Patients · Phase 1, PHASE2 · recruiting
NCT06970626 — Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in C · Phase 2, PHASE3 · recruiting
NCT05283408 — The Clinical Study of Dexmedetomidine and Esketamine Combined Infusion Undergoing Modified Radical Mastectomy · NA · completed

Other recruiting trials for Pre-Eclampsia

Currently open trials in the same condition.

NCT07245056 — Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia · NA · recruiting
NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
NCT06893510 — Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia · NA · recruiting
NCT06122220 — Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia. · NA · recruiting
NCT06779916 — Autophagy/Apoptosis Balance in Placental Vascular Pathologies · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03391609 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 26 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03391609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing